Pro-Inflammatory Alterations of Circulating Monocytes in Latent Tuberculosis Infection
Authors:
Open Access
- 19 November 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 9 (12) , ofac629
Abstract
Latent tuberculosis infection (LTBI) has been associated with increased cardiovascular risk. We investigated the activation and pro-inflammatory profile of monocytes in individuals with LTBI and their association with coronary artery disease (CAD). Individuals 40–70 years old in Lima, Peru, underwent QuantiFERON-TB testing to define LTBI, completed a coronary computed tomography angiography to evaluate CAD, and provided blood for monocyte profiling using flow cytometry. Cells were stimulated with lipopolysaccharide to assess interleukin-6 (IL-6) and tumor necrosis factor (TNF)–α responses. The clinical characteristics of the LTBI (n = 28) and non-LTBI (n = 41) groups were similar. All monocyte subsets from LTBI individuals exhibited higher mean fluorescence intensity (MFI) of CX3CR1 and CD36 compared with non-LTBI individuals. LTBI individuals had an increased proportion of nonclassical monocytes expressing IL-6 (44.9 vs 26.9; P = .014), TNF-α (62.3 vs 35.1; P = .014), and TNF-α+IL-6+ (43.2 vs 36.6; P = .042). Among LTBI individuals, CAD was associated with lower CX3CR1 MFI on classical monocytes and lower CD36 MFI across all monocyte subsets. In multivariable analyses, lower CD36 MFI on total monocytes (b = −0.17; P = .002) and all subsets remained independently associated with CAD in LTBI. Individuals with LTBI have distinct monocyte alterations suggestive of an exacerbated inflammatory response and tissue migration. Whether these alterations contribute to cardiovascular disease pathogenesis warrants further investigation.Keywords
Funding Information
- National Center for Advancing Translational Sciences (KL2 TR001426, R03TR004097)
- National Institute of Allergy and Infectious Diseases (UM1AI069501)
- National Heart, Lung, and Blood Institute (1R01HL156779)
- National Institutes of Health
This publication has 56 references indexed in Scilit:
- Soluble Markers of the Toll-Like Receptor 4 Pathway Differentiate between Active and Latent Tuberculosis and Are Associated with Treatment ResponsesPLOS ONE, 2013
- Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndromeBlood, 2012
- Mycobacterium tuberculosis Activates Human Macrophage Peroxisome Proliferator-Activated Receptor γ Linking Mannose Receptor Recognition to Regulation of Immune ResponsesThe Journal of Immunology, 2010
- Monocytes in atherosclerosis: subsets and functionsNature Reviews Cardiology, 2010
- The spectrum of latent tuberculosis: rethinking the biology and intervention strategiesNature Reviews Microbiology, 2009
- A replication clock for Mycobacterium tuberculosisNature Medicine, 2009
- Monitoring of Blood Vessels and Tissues by a Population of Monocytes with Patrolling BehaviorScience, 2007
- Functional and phenotypic changes in monocytes from patients with tuberculosis are reversed with treatmentMicrobes and Infection, 2006
- CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolismJournal of Clinical Investigation, 2001
- Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen speciesJournal of Clinical Investigation, 2000